← The Wire
BHVNNYSE
Biohaven Ltd.
Pharmaceutical Preparations · D8 · CIK 1935979
Biohaven discovers, develops, and commercializes life-changing treatments in immunology, neuroscience, and oncology
⚡ Elevated coverage
$1.70B
Market cap
$14.95
Last close
-5.6%
1D
-3.5%
5D
3.5M
Volume
Price · last 39 sessions+47.4%
May 4L $8.39 · H $15.83Jun 29
90
Total filings
May 27, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureMay 27, 20268-KCompany UpdateMay 5, 2026424B5424B5May 4, 202610-Q10-QMay 4, 20268-KResults of OperationsMay 4, 20268-KShareholder VoteMay 4, 2026DEFA14ADEFA14AMar 13, 2026DEF 14ADEF 14AMar 13, 20268-KResults of OperationsMar 2, 202610-K10-KMar 2, 20268-KReg FD DisclosureJan 12, 20268-KCompany UpdateJan 7, 20268-KCompany UpdateNov 13, 2025424B5424B5Nov 13, 2025424B5424B5Nov 12, 202510-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KReg FD DisclosureAug 22, 20258-KCompany UpdateAug 15, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KReg FD DisclosureJun 4, 20258-KReg FD DisclosureMay 15, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 20258-KShareholder VoteMay 7, 20258-KMaterial Agreement · New Debt / ObligationApr 28, 2025DEFA14ADEFA14AMar 18, 2025DEF 14ADEF 14AMar 18, 20258-KResults of OperationsMar 3, 202510-K10-KMar 3, 20258-KReg FD DisclosureJan 13, 20258-KResults of OperationsNov 12, 202410-Q10-QNov 12, 20248-KCompany UpdateOct 2, 2024424B5424B5Oct 1, 2024424B5424B5Sep 30, 20248-KReg FD Disclosure · Company UpdateSep 23, 20248-KCompany UpdateAug 16, 20248-KCompany UpdateAug 16, 2024424B5424B5Aug 16, 202410-Q10-QAug 9, 20248-KResults of OperationsAug 8, 20248-KCompany UpdateMay 17, 20248-KResults of OperationsMay 9, 202410-Q10-QMay 9, 20248-KShareholder VoteMay 1, 20248-KCompany UpdateApr 22, 2024424B5424B5Apr 19, 2024424B5424B5Apr 17, 20248-KReg FD DisclosureApr 15, 2024DEFA14ADEFA14AMar 18, 2024DEF 14ADEF 14AMar 18, 20248-KCompany UpdateMar 12, 20248-KResults of OperationsFeb 29, 202410-K10-KFeb 29, 2024SC 13GSC 13GFeb 6, 20248-KReg FD DisclosureJan 8, 20248-KResults of OperationsNov 14, 202310-Q10-QNov 14, 2023SC 13GBIOHAVEN LTD.Oct 18, 20238-KCompany UpdateOct 5, 2023424B5424B5Oct 4, 20238-KCompany UpdateOct 3, 2023424B5424B5Oct 2, 2023424B5424B5Oct 2, 20238-KReg FD DisclosureSep 27, 202310-Q10-QJul 31, 20238-KResults of OperationsJul 31, 20238-KReg FD DisclosureJul 28, 20238-KReg FD DisclosureMay 31, 20238-KResults of OperationsMay 12, 202310-Q10-QMay 12, 20238-KExecutive Change · Shareholder VoteMay 4, 20238-KReg FD DisclosureMar 24, 20238-KResults of OperationsMar 23, 2023DEFA14ADEFA14AMar 23, 2023DEF 14ADEF 14AMar 23, 202310-K10-KMar 23, 2023SC 13GSC 13GFeb 13, 2023
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Nov 17, 2025: 4 insiders bought $30.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Clark George C.VP, Chief Accounting Officer | Buy | 17,000 | $8.52 | $145K |
| Nov 13, 2025 | Childs John WDirector | Buy | 3,333,333 | $7.50 | $25.0M |
| Nov 13, 2025 | Bailey GregoryDirector | Buy | 400,000 | $7.50 | $3.0M |
| Nov 13, 2025 | Coric VladChief Executive Officer | Buy | 333,333 | $7.50 | $2.5M |
| Mar 4, 2025 | Childs John WDirector | Buy | 28,400 | $30.43 | $864K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance